Proffitt & Goodson’s Medtronic MDT Stock Holding History

Proffitt & Goodson’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-145	Closed	-$13.8K	–	384
2025 Q3	$13.8K	Buy	+145	New	+$13.3K	﹤0.01%	223
2022 Q3	–	Sell	-249	Closed	-$22K	–	256
2022 Q2	$22K	Hold	249	–	–	﹤0.01%	190
2022 Q1	$28K	Hold	249	–	–	0.01%	197
2021 Q4	$26K	Hold	249	–	–	﹤0.01%	178
2021 Q3	$31K	Sell	249 -427	-63%	-$55.3K	0.01%	172
2021 Q2	$84K	Sell	676 -27	-4%	-$3.39K	0.02%	138
2021 Q1	$83K	Hold	703	–	–	0.02%	136
2020 Q4	$82K	Buy	703 +292	+71%	+$32.1K	0.02%	132
2020 Q3	$43K	Hold	411	–	–	0.01%	147
2020 Q2	$38K	Hold	411	–	–	0.01%	156
2020 Q1	$37K	Hold	411	–	–	0.01%	124
2019 Q4	$47K	Hold	411	–	–	0.01%	129
2019 Q3	$45K	Hold	411	–	–	0.01%	128
2019 Q2	$40K	Hold	411	–	–	0.01%	127
2019 Q1	$37K	Hold	411	–	–	0.01%	124
2018 Q4	$37K	Hold	411	–	–	0.01%	92
2018 Q3	$40K	Buy	+411	New	+$38K	0.01%	83

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Proffitt & Goodson's MDT Position: Q4 2025 in Review

Proffitt & Goodson sold out of Medtronic (MDT) in Q4 2025, closing a stake of 145 shares — an estimated $13.8K sold.

Proffitt & Goodson first reported a position in MDT in Q3 2018 and held it in 17 quarters. The position peaked at $84K in Q2 2021. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

Proffitt & Goodson reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
Proffitt & Goodson sold 145 Medtronic shares in Q4 2025, an estimated $13.8K.
Proffitt & Goodson first reported a position in Medtronic in Q3 2018 and held it in 17 quarters.
Proffitt & Goodson's Medtronic position peaked at $84K in Q2 2021.
2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Proffitt & Goodson's 13F filing for Q4 2025, filed 27 Jan 2026.